Infosys CEO Salil Parekh says he's comfortable with recently-raised full-year revenue growth outlook of 14%-16%
Eight of the 10 most valued firms together added Rs 98,234.82 crore in market valuation last week, with IT majors Infosys and TCS emerging as the biggest gainers amid a positive momentum in equities
MindTree, Mphasis and Larsen & Toubro Infotech may rally up to 24 per cent, while Infosys needs to overcome its near-term hurdle for fresh gains.
Revenue was at $4.9 billion, up 9.5 per cent in constant currency on a year-on-year (YoY) basis
Going ahead, brokerages believe that the margin headwinds like travel costs, wage inflation will continue to persist in Q2FY23 as well.
Talent retention has eroded not only their margins but also any gains they may have made from rupee depreciation
CLOSING BELL: Among sectors, the Nifty Auto fell 1.7 per cent, while the Nifty Metal added 1.5 per cent
India's tech industry is ruling out a US recession. Or so you would think from Infosys Ltd.'s cheery forecast of 14 per cent to 16 per cent annual revenue growth
ICICI Bank can rally to a new high if the stock manages to sustain above its 200-DMA; Infosys and UltraTech Cement too look promising, while Rs 2,350-level remains the key for Reliance Industries.
Stocks to watch today: Axis Bank, Tata Steel will report their June quarter 2022 results (Q1FY23) on Monday, July 25; Infosys delivered net profit for Q1 below street expectations at Rs 5,360 crore.
Its net profit for Q1FY23 was below expectations at Rs 5,360 crore, up 3.2 per cent year-on-year (YoY) but was down 5.7 per cent sequentially
Revenue up nearly 24% YoY to Rs 34,470 cr; attrition rate rises to 28.4% in Q1FY23, from 13.9% a year ago and 27.7% in the immediately preceding quarter
Infosys Q1 preview: Investors will closely monitor the management's commentary on clients' IT spending, demand environment amid macro stress, margin outlook, and growth guidance for FY23
Among select export-oriented shares, Aurobindo Pharma seems well placed on the charts with a potential upside of 9 per cent in the near term.
What's the significance of the US remittances to India? Why over-tourism may spell trouble for tourist spots? Why are Infosys and Wipro staring at modest Q1 revenues? What's Apple's Lockdown Mode?
After IT majors TCS and HCL Technologies disappointed the Street with somber June quarter numbers, analysts expect Infosys and Wipro to follow a similar trend. Find out what investors should expect
The founder of IT major Infosys also highlighted the need to recognise frontline research warriors in war against India's "grand problems"
Stocks to watch today: Tata Elxsi, L&T Infotech will report their June quarter results 2022 on Thursday July 14; Mindtree posted 37.3 per cent rise in net profit to Rs 471.6 crore for Q1FY23.
Infosys on Wednesday said it will acquire Denmark-based BASE life science for about 110 million euros (Rs 875 crore) in an all-cash deal. The acquisition will deepen Infosys' expertise in life sciences domain as well as strengthen its footprint across Europe. "This acquisition augments Infosys' deep life sciences expertise, and expands our footprint further in the Nordics region and across Europe, and scales our digital transformation capabilities with cloud-based industry solutions. "We are excited to welcome BASE life science and its leadership team into the Infosys family," Infosys president Ravi Kumar S said. The deal is expected to close during the second quarter of current fiscal. BASE brings to Infosys, domain experts with commercial, medical, digital marketing, clinical, regulatory, and quality knowhow. "Backed by a team of data science specialists, BASE is at the frontier of the latest technological developments and trends. It has a strong focus on Data & AI, and the ...
Unabated foreign fund outflows and the rupee dropping to another record low against the dollar added to the woes, traders said